This recall is currently ongoing, and the associated recall number is recall number is D-0167-2025. It pertains to Levothyroxine Sodium identified by 68180-965.

A Class II recall has been issued for multiple strengths of Levothyroxine Sodium Tablets due to subpotency, potentially compromising the treatment of hypothyroidism in patients nationwide.

Accord Healthcare, Inc. (“Accord Healthcare”) is voluntarily recalling four lots of Levothyroxine Sodium Tablets USP 25 mcg, 50 mcg, 88 mcg and 112 mcg, at the Pharmacy Level.

IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated because these lots may …

Dec 23, 2024 · Description: Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, …

2 days ago · Roughly 160,630 bottles of levothyroxine sodium tablets are under recall, the FDA said.

Feb 2, 2023 · On Feb. 1, the FDA announced that IBSA Pharma Inc. had issued a voluntary recall of specific lots of its TIROSINT-SOL (levothyroxine sodium) Oral Solution medication.

Feb 8, 2023 · A voluntary recall has been issued for an oral solution of levothyroxine sodium due to possible subpotency among some of the manufactured products, according to a company …

Apr 30, 2021 · FDA does not endorse either the product or the company. Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60 …

11 hours ago · The Food and Drug Administration (FDA) this week upgraded a recall of tens of thousands of bottles of a type of commonly prescribed thyroid medication. The recall was …